ANDA 79007, held by Sandoz. Anastrozole.
As of Nov 16, 2026, ANDA 79007 (Anastrozole), held by Sandoz, was first approved by FDA on Jun 28, 2010, with 4 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jun 28, 2010 | Original application | Approved |
| Product | Active ingredient | Marketing |
|---|---|---|
| Anastrozole1MG · tablet;oral | Anastrozole | Discontinued |
| Oct 24, 2025 | Supplement 5Labeling · Standard review | Approved | None posted |
| Aug 13, 2015 | Supplement 2Labeling · Standard review | Approved | None posted |
| Aug 13, 2015 | Supplement 4Labeling · Standard review | Approved | None posted |
| Nov 28, 2011 | Supplement 1Labeling | Approved | None posted |
| Jun 28, 2010 | Original application | Approved |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters